MXPA05010709A - Combinacion de un macrolido y un anestesico local para el tratamiento de enfermedades dermatologicas. - Google Patents
Combinacion de un macrolido y un anestesico local para el tratamiento de enfermedades dermatologicas.Info
- Publication number
- MXPA05010709A MXPA05010709A MXPA05010709A MXPA05010709A MXPA05010709A MX PA05010709 A MXPA05010709 A MX PA05010709A MX PA05010709 A MXPA05010709 A MX PA05010709A MX PA05010709 A MXPA05010709 A MX PA05010709A MX PA05010709 A MXPA05010709 A MX PA05010709A
- Authority
- MX
- Mexico
- Prior art keywords
- macrolide
- treatment
- dermatological diseases
- combination
- local anesthetic
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 239000003120 macrolide antibiotic agent Substances 0.000 title abstract 2
- 239000003589 local anesthetic agent Substances 0.000 title 1
- 208000003251 Pruritus Diseases 0.000 abstract 2
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 1
- 206010012442 Dermatitis contact Diseases 0.000 abstract 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 abstract 1
- 229920001363 Polidocanol Polymers 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- 230000003444 anaesthetic effect Effects 0.000 abstract 1
- 201000008937 atopic dermatitis Diseases 0.000 abstract 1
- 208000010247 contact dermatitis Diseases 0.000 abstract 1
- 239000002955 immunomodulating agent Substances 0.000 abstract 1
- 229940121354 immunomodulator Drugs 0.000 abstract 1
- 230000002584 immunomodulator Effects 0.000 abstract 1
- 229960003444 immunosuppressant agent Drugs 0.000 abstract 1
- 230000001861 immunosuppressant effect Effects 0.000 abstract 1
- 239000003018 immunosuppressive agent Substances 0.000 abstract 1
- 230000007803 itching Effects 0.000 abstract 1
- 229960004194 lidocaine Drugs 0.000 abstract 1
- KASDHRXLYQOAKZ-OLHLVPFQSA-N pimecrolimus Chemical compound C/C([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](OC)C[C@@H](C)C\C(C)=C/[C@H](C(C[C@H](O)[C@H]1C)=O)CC)=C\[C@@H]1CC[C@H](Cl)[C@H](OC)C1 KASDHRXLYQOAKZ-OLHLVPFQSA-N 0.000 abstract 1
- ONJQDTZCDSESIW-UHFFFAOYSA-N polidocanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO ONJQDTZCDSESIW-UHFFFAOYSA-N 0.000 abstract 1
- 229960002226 polidocanol Drugs 0.000 abstract 1
- 229960001807 prilocaine Drugs 0.000 abstract 1
- MVFGUOIZUNYYSO-UHFFFAOYSA-N prilocaine Chemical compound CCCNC(C)C(=O)NC1=CC=CC=C1C MVFGUOIZUNYYSO-UHFFFAOYSA-N 0.000 abstract 1
- 201000004700 rosacea Diseases 0.000 abstract 1
- 208000008742 seborrheic dermatitis Diseases 0.000 abstract 1
- 239000011885 synergistic combination Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0307869.8A GB0307869D0 (en) | 2003-04-04 | 2003-04-04 | Pharmaceutical composition |
| PCT/EP2004/003515 WO2004087144A1 (en) | 2003-04-04 | 2004-04-02 | Combination of a macrolide and a local anesthetic for the treatment of dermatological diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05010709A true MXPA05010709A (es) | 2005-12-12 |
Family
ID=9956231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05010709A MXPA05010709A (es) | 2003-04-04 | 2004-04-02 | Combinacion de un macrolido y un anestesico local para el tratamiento de enfermedades dermatologicas. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20060110448A1 (https=) |
| EP (1) | EP1613317A1 (https=) |
| JP (1) | JP2006522061A (https=) |
| CN (1) | CN1771036A (https=) |
| AU (1) | AU2004226823A1 (https=) |
| BR (1) | BRPI0409207A (https=) |
| CA (1) | CA2521261A1 (https=) |
| GB (1) | GB0307869D0 (https=) |
| IS (1) | IS8106A (https=) |
| MX (1) | MXPA05010709A (https=) |
| NO (1) | NO20055137L (https=) |
| RS (1) | RS20050752A (https=) |
| WO (1) | WO2004087144A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9687455B2 (en) | 2014-08-14 | 2017-06-27 | John Daniel Dobak | Sodium tetradecyl sulfate formulations for treatment of adipose tissue |
| US9351945B1 (en) | 2015-02-27 | 2016-05-31 | John Daniel Dobak, III | Reduction of adipose tissue |
| KR102141441B1 (ko) * | 2018-06-28 | 2020-08-05 | 이환석 | 무출혈 무통필름 |
| CN108853312B (zh) * | 2018-09-25 | 2021-04-16 | 陕西天宇制药有限公司 | 聚桂醇外用凝胶及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB766245A (en) * | 1954-09-03 | 1957-01-16 | Lilly Co Eli | Therapeutic preparations containing erythromycin |
| HU194493B (en) * | 1985-11-27 | 1988-02-29 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing primycin-containing colloidal basic gel and compositions comprising the same |
| JPH08133979A (ja) * | 1994-09-16 | 1996-05-28 | Sando Yakuhin Kk | 局所適用薬剤組成物 |
| CN100335063C (zh) * | 1994-10-26 | 2007-09-05 | 诺瓦蒂斯有限公司 | 药物组合物 |
| CN1158258A (zh) * | 1996-12-11 | 1997-09-03 | 李志辉 | 秦云创伤外用药 |
| GB9723669D0 (en) * | 1997-11-07 | 1998-01-07 | Univ Aberdeen | Skin penetration enhancing components |
| US6120792A (en) * | 1998-04-29 | 2000-09-19 | Juni; Jack E. | Medicated skin patch and method for its use |
| JP2001288086A (ja) * | 1999-07-21 | 2001-10-16 | Shoei:Kk | 皮膚疾患の治療用又は予防用外用剤 |
| JP2001288085A (ja) * | 1999-07-21 | 2001-10-16 | Shoei:Kk | 乾癬の治療用又は予防用外用剤 |
| GB0003932D0 (en) * | 2000-02-18 | 2000-04-12 | Novartis Ag | Pharmaceutical compositions |
| WO2002062353A1 (en) * | 2001-02-05 | 2002-08-15 | Marie Madeline Wharton | Composition containing sucrafate and a topical anesthetic for human and animals and method of use thereof |
| RU2195279C1 (ru) * | 2001-07-10 | 2002-12-27 | Тульский государственный университет | Способ лечения отморожений |
| CN1189193C (zh) * | 2001-09-10 | 2005-02-16 | 黄家伶 | 烧伤药膏 |
| CN1197576C (zh) * | 2002-08-30 | 2005-04-20 | 孙万一 | 治疗性病疣的药物及其制备方法 |
-
2003
- 2003-04-04 GB GBGB0307869.8A patent/GB0307869D0/en not_active Ceased
-
2004
- 2004-02-04 US US10/550,360 patent/US20060110448A1/en not_active Abandoned
- 2004-04-02 WO PCT/EP2004/003515 patent/WO2004087144A1/en not_active Ceased
- 2004-04-02 MX MXPA05010709A patent/MXPA05010709A/es not_active Application Discontinuation
- 2004-04-02 BR BRPI0409207-4A patent/BRPI0409207A/pt not_active IP Right Cessation
- 2004-04-02 RS YUP-2005/0752A patent/RS20050752A/sr unknown
- 2004-04-02 AU AU2004226823A patent/AU2004226823A1/en not_active Abandoned
- 2004-04-02 EP EP04725354A patent/EP1613317A1/en not_active Withdrawn
- 2004-04-02 CA CA002521261A patent/CA2521261A1/en not_active Abandoned
- 2004-04-02 CN CNA2004800092493A patent/CN1771036A/zh active Pending
- 2004-04-02 JP JP2006504968A patent/JP2006522061A/ja active Pending
-
2005
- 2005-10-31 IS IS8106A patent/IS8106A/is unknown
- 2005-11-02 NO NO20055137A patent/NO20055137L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2521261A1 (en) | 2004-10-14 |
| CN1771036A (zh) | 2006-05-10 |
| IS8106A (is) | 2005-10-31 |
| JP2006522061A (ja) | 2006-09-28 |
| AU2004226823A1 (en) | 2004-10-14 |
| NO20055137L (no) | 2006-01-04 |
| US20060110448A1 (en) | 2006-05-25 |
| RS20050752A (sr) | 2007-11-15 |
| GB0307869D0 (en) | 2003-05-14 |
| NO20055137D0 (no) | 2005-11-02 |
| BRPI0409207A (pt) | 2006-03-28 |
| WO2004087144A1 (en) | 2004-10-14 |
| EP1613317A1 (en) | 2006-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009006007A (es) | Profarmacos y metodos para hacer y usar los mismos. | |
| WO2004093814A3 (en) | Compositions of a cyclooxygenase-2 selective inhibitor and a sodium channel blocker | |
| PT1420801E (pt) | Utilização de fucanos no tratamento de adesões, artrite e psoríase | |
| MXPA05011656A (es) | Combinaciones para el tratamiento de enfermedades que implican proliferacion, migracion o apoptosis celulares de celulas de mieloma, o angiogenesis. | |
| IL171607A (en) | Use of botulinum toxin for the treatment of sinusitis-induced headaches | |
| WO2006113802A3 (en) | Device for administering electrode stimulation of back and abdominal muscles | |
| WO2009061916A3 (en) | Benzodiazepinone compounds useful in the treatment of skin conditions | |
| WO2001078706A3 (en) | Treatment of hyperproliferative, inflammatory and related mucocutaneous disorders using inhibitors of mevalonate synthesis and metabolism | |
| WO2003092617A3 (en) | Combinations for the treatment of inflammatory skin disorders | |
| WO2009129531A3 (en) | Bupivacaine formulation in a polyorthoester carrier | |
| WO2007112453A3 (en) | Methods amd compositions for treating conditions | |
| TW200731978A (en) | User-adjustable treatment methods, systems and compositions for treating acne | |
| WO2005037323A3 (en) | Use of gro to treat or prevent inflammation | |
| MXPA05010708A (es) | Composicion farmaceutica que comprende un inmunosupresor para utilizarse en el tratamiento de enfermedades de la piel. | |
| EP1628667A4 (en) | METHOD FOR TREATING DISEASES USING HSP90 INHIBITION AGENTS COMBINED WITH ANTIMITOTICS | |
| WO2008058210A3 (en) | Local administration of gallium compositions to treat pain | |
| PT1255564E (pt) | Composicao farmaceutica | |
| WO2004073622A3 (en) | Novel therapeutic method and compositions for topical administration | |
| WO2007065289A3 (en) | 4-oxo-(iso)tretinoin for the topical treatment of severe dermatological disorders | |
| MXPA05010709A (es) | Combinacion de un macrolido y un anestesico local para el tratamiento de enfermedades dermatologicas. | |
| WO2004058329A3 (en) | Ester combination local anesthetic | |
| WO2008049903A3 (en) | Wide-area parasystemic treatment of skin related conditions | |
| WO2004105689A3 (en) | Topical composition for the treatment of skin disorders and methods of using the same | |
| BRPI0415225A (pt) | composições tópicas compreendendo telmesteìna para o tratamento de distúrbios dermatológicos | |
| WO2005016381A3 (en) | Combination therapy for the treatment and prevention of cancer using epha2, pcdgf, and haah |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |